US Patent 12065448 Heteroaryl plasma kallikrein inhibitors
Patent 12065448 was granted and assigned to Takeda Pharmaceutical Company on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+190 characters)
US Patent 12065448 Heteroaryl plasma kallikrein inhibitors
Article
Patent abstract
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alastair Rae0
Jeremy Mark Travins0
John Mark Ellard0
Nikolaos Papaioannou0
Sarah Jocelyn Fink0
Date of Patent
August 20, 2024
0Patent Application Number
178317160
Date Filed
June 3, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12065448 Heteroaryl plasma kallikrein inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
